Efrat Finkin-Groner

486 total citations
12 papers, 397 citations indexed

About

Efrat Finkin-Groner is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Efrat Finkin-Groner has authored 12 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in Efrat Finkin-Groner's work include Cholinesterase and Neurodegenerative Diseases (4 papers), Computational Drug Discovery Methods (3 papers) and Adenosine and Purinergic Signaling (2 papers). Efrat Finkin-Groner is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (4 papers), Computational Drug Discovery Methods (3 papers) and Adenosine and Purinergic Signaling (2 papers). Efrat Finkin-Groner collaborates with scholars based in Israel, United States and Germany. Efrat Finkin-Groner's co-authors include Marta Weinstock, Abraham Nudelman, Qingfei Zheng, Yael David, Sarat Chandarlapaty, Bo Liu, Albert S. Agustinus, Adewola Osunsade, Rachel Leicher and Nathaniel D. Omans and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Efrat Finkin-Groner

12 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Efrat Finkin-Groner Israel 9 188 98 73 52 48 12 397
Michelle M. Mitchener United States 11 309 1.6× 30 0.3× 80 1.1× 44 0.8× 38 0.8× 20 452
Robert J. Chalifour Canada 9 314 1.7× 56 0.6× 29 0.4× 81 1.6× 196 4.1× 10 488
Ashraf Raza United States 10 324 1.7× 56 0.6× 31 0.4× 62 1.2× 79 1.6× 12 554
Alexander Yurek‐George United Kingdom 6 270 1.4× 142 1.4× 141 1.9× 37 0.7× 63 1.3× 8 478
Hongchan An South Korea 14 228 1.2× 180 1.8× 33 0.5× 57 1.1× 34 0.7× 35 482
Sergio Porté Spain 16 361 1.9× 52 0.5× 19 0.3× 66 1.3× 48 1.0× 23 637
Jeanne M. Rumsey United States 6 238 1.3× 30 0.3× 54 0.7× 28 0.5× 19 0.4× 7 337
Ken-ichiro Kataoka Japan 8 166 0.9× 83 0.8× 19 0.3× 97 1.9× 239 5.0× 8 474
Johanna Huttunen Finland 14 262 1.4× 29 0.3× 51 0.7× 22 0.4× 40 0.8× 23 554
Hideshi Kaneko Japan 4 157 0.8× 24 0.2× 20 0.3× 95 1.8× 243 5.1× 11 448

Countries citing papers authored by Efrat Finkin-Groner

Since Specialization
Citations

This map shows the geographic impact of Efrat Finkin-Groner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Finkin-Groner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Finkin-Groner more than expected).

Fields of papers citing papers by Efrat Finkin-Groner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Finkin-Groner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Finkin-Groner. The network helps show where Efrat Finkin-Groner may publish in the future.

Co-authorship network of co-authors of Efrat Finkin-Groner

This figure shows the co-authorship network connecting the top 25 collaborators of Efrat Finkin-Groner. A scholar is included among the top collaborators of Efrat Finkin-Groner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Efrat Finkin-Groner. Efrat Finkin-Groner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Feng, Qing He, Wenhu Zhan, et al.. (2023). Structure of the human UBR5 E3 ubiquitin ligase. Structure. 31(5). 541–552.e4. 21 indexed citations
2.
Miller, Michael, Melanie Balbach, Navpreet Kaur, et al.. (2022). Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates. Journal of Medicinal Chemistry. 65(22). 15208–15226. 14 indexed citations
3.
Finkin-Groner, Efrat, Yoshiyuki Fukase, Qingfei Zheng, et al.. (2021). Deglycase-activity oriented screening to identify DJ-1 inhibitors. RSC Medicinal Chemistry. 12(7). 1232–1238. 17 indexed citations
4.
Fushimi, Makoto, Melanie Balbach, Navpreet Kaur, et al.. (2021). Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10). ACS Medicinal Chemistry Letters. 12(8). 1283–1287. 18 indexed citations
5.
Zheng, Qingfei, Nathaniel D. Omans, Rachel Leicher, et al.. (2019). Reversible histone glycation is associated with disease-related changes in chromatin architecture. Nature Communications. 10(1). 1289–1289. 148 indexed citations
6.
Finkin-Groner, Efrat, et al.. (2018). Synthesis and Biological Evaluation of Derivatives of Indoline as Highly Potent Antioxidant and Anti-inflammatory Agents. Journal of Medicinal Chemistry. 61(9). 4004–4019. 52 indexed citations
7.
Finkin-Groner, Efrat, et al.. (2017). Indoline derivatives mitigate liver damage in a mouse model of acute liver injury. Pharmacological Reports. 69(5). 894–902. 6 indexed citations
8.
Finkin-Groner, Efrat, Corina Bejar, Priyashree Sunita, et al.. (2015). Dose-limiting inhibition of acetylcholinesterase by ladostigil results from the rapid formation and fast hydrolysis of the drug–enzyme complex formed by its major metabolite, R-MCPAI. Biochemical Pharmacology. 94(2). 164–172. 6 indexed citations
9.
Weitman, Michal, et al.. (2014). Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages. Bioorganic & Medicinal Chemistry Letters. 24(10). 2283–2287. 26 indexed citations
10.
Finkin-Groner, Efrat, et al.. (2014). Indoline‐3‐propionate and 3‐aminopropyl carbamates reduce lung injury and pro‐inflammatory cytokines induced in mice by LPS. British Journal of Pharmacology. 172(4). 1101–1113. 21 indexed citations
11.
Finkin-Groner, Efrat, et al.. (2013). 80. Cytokine. 63(3). 262–262. 2 indexed citations
12.
Finkin-Groner, Efrat, et al.. (2012). Carbamate Derivatives of Indolines as Cholinesterase Inhibitors and Antioxidants for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry. 55(23). 10700–10715. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle M. Mitchener Breakdown of academic impact, for papers by Robert J. Chalifour Breakdown of academic impact, for papers by Ashraf Raza Breakdown of academic impact, for papers by Alexander Yurek‐George Breakdown of academic impact, for papers by Hongchan An Breakdown of academic impact, for papers by Sergio Porté Breakdown of academic impact, for papers by Jeanne M. Rumsey Breakdown of academic impact, for papers by Ken-ichiro Kataoka Breakdown of academic impact, for papers by Johanna Huttunen Breakdown of academic impact, for papers by Hideshi Kaneko
Rankless by CCL
2026